UMass Chan - Baystate Critical Care Medicine (Internal Medicine)

Topics

• Sepsis Diagnosis and Treatment 46
• Lung Cancer Diagnosis and Treatment 25
• Respiratory Support and Mechanisms 25
• SARS-CoV-2 and COVID-19 Research 23
• Cardiac, Anesthesia and Surgical Outcomes 19
• Palliative Care and End-of-Life Issues 13
• Chronic Obstructive Pulmonary Disease (COPD) Research 12
• Influenza Virus Research Studies 9
• Respiratory viral infections research 9
• Venous Thromboembolism Diagnosis and Management 9
• Pleural and Pulmonary Diseases 8
• Hemodynamic Monitoring and Therapy 7

Most cited

1. Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension.

   The New England journal of medicine · 2023 · 296 citations · Jay Steingrub

2. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study.

   BMJ (Clinical research ed.) · 2022 · 544 citations · Jay Steingrub

3. Association Between mRNA Vaccination and COVID-19 Hospitalization and Disease Severity.

   JAMA · 2021 · 522 citations · Jay Steingrub

4. Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.

   Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026 · 41 citations · Jay Steingrub

5. Interim Estimates of 2024-2025 COVID-19 Vaccine Effectiveness Among Adults Aged ≥18 Years - VISION and IVY Networks, September 2024-January 2025.

   MMWR. Morbidity and mortality weekly report · 2025 · 79 citations · Jay Steingrub

6. Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions - United States, March-August 2021.